Philip LoBue

8.2k total citations · 3 hit papers
44 papers, 4.6k citations indexed

About

Philip LoBue is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Philip LoBue has authored 44 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 31 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Philip LoBue's work include Tuberculosis Research and Epidemiology (40 papers), Mycobacterium research and diagnosis (21 papers) and Diagnosis and treatment of tuberculosis (13 papers). Philip LoBue is often cited by papers focused on Tuberculosis Research and Epidemiology (40 papers), Mycobacterium research and diagnosis (21 papers) and Diagnosis and treatment of tuberculosis (13 papers). Philip LoBue collaborates with scholars based in United States, United Kingdom and Switzerland. Philip LoBue's co-authors include Charles O. Thoen, Kathleen Moser, Robert Pratt, Lori Armstrong, Theresa Harrington, David L. Cohn, Timothy R. Sterling, Dick Menzies, Gerald H. Mazurek and Charles L. Daley and has published in prestigious journals such as JAMA, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Philip LoBue

44 papers receiving 4.4k citations

Hit Papers

Official American Thoracic Society/Infectious Disea... 2009 2026 2014 2020 2016 2009 2017 200 400 600

Peers

Philip LoBue
Philip LoBue
Citations per year, relative to Philip LoBue Philip LoBue (= 1×) peers Ian Schiller

Countries citing papers authored by Philip LoBue

Since Specialization
Citations

This map shows the geographic impact of Philip LoBue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip LoBue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip LoBue more than expected).

Fields of papers citing papers by Philip LoBue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip LoBue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip LoBue. The network helps show where Philip LoBue may publish in the future.

Co-authorship network of co-authors of Philip LoBue

This figure shows the co-authorship network connecting the top 25 collaborators of Philip LoBue. A scholar is included among the top collaborators of Philip LoBue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip LoBue. Philip LoBue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langer, Adam J., Thomas R. Navin, Carla A. Winston, & Philip LoBue. (2019). Epidemiology of Tuberculosis in the United States. Clinics in Chest Medicine. 40(4). 693–702. 21 indexed citations
2.
LoBue, Philip & Jonathan Mermin. (2017). Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA. The Lancet Infectious Diseases. 17(10). e327–e333. 81 indexed citations
3.
Olea‐Popelka, Francisco, Adrian Muwonge, Anna Dean, et al.. (2016). Zoonotic tuberculosis in human beings caused by Mycobacterium bovis—a call for action. The Lancet Infectious Diseases. 17(1). e21–e25. 243 indexed citations
4.
Castro, Kenneth G., Suzanne M. Marks, Andrew Hill, et al.. (2016). Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades. The International Journal of Tuberculosis and Lung Disease. 20(7). 926–933. 23 indexed citations
5.
Cavanaugh, Joseph S., et al.. (2016). Human Tuberculosis Caused byMycobacterium bovisin the United States, 2006–2013. Clinical Infectious Diseases. 63(5). 594–601. 32 indexed citations
6.
Thoen, Charles O., Philip LoBue, Donald A. Enarson, John B. Kaneene, & Isabel N Kantor. (2012). Tuberculosis: a re-emerging disease in animals and humans.. PubMed. 45(1). 135–81. 81 indexed citations
7.
LoBue, Philip & Kenneth G. Castro. (2012). Is It Time to Replace the Tuberculin Skin Test With a Blood Test?. JAMA. 308(3). 241–241. 17 indexed citations
8.
Kellar, Kathryn L., Stephen E. Weis, Blachy J. Dávila Saldaña, et al.. (2011). Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens. PLoS ONE. 6(11). e26545–e26545. 65 indexed citations
9.
Castro, Kenneth G., Philip LoBue, & Christine Sizemore. (2009). Plan to combat extensively drug-resistant tuberculosis; recommendations of the Federal Tuberculosis Task Force. MMWR Morbidity and Mortality Weekly Report. 58. 1–43. 50 indexed citations
10.
Pratt, Robert, et al.. (2009). Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006. Clinical Infectious Diseases. 49(9). 1350–1357. 488 indexed citations breakdown →
11.
Winthrop, Kevin, et al.. (2009). Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy. Emerging infectious diseases. 15(10). 1556–1561. 204 indexed citations
12.
Hlavsa, Michele C., Patrick K. Moonan, Lauren S. Cowan, et al.. (2008). Human Tuberculosis due toMycobacterium bovisin the United States, 1995–2005. Clinical Infectious Diseases. 47(2). 168–175. 112 indexed citations
13.
Mazurek, Gerald H., Arlene Hankinson, Sean Toney, et al.. (2007). Detection of Mycobacterium tuberculosis Infection in United States Navy Recruits Using the Tuberculin Skin Test or Whole-Blood Interferon-  Release Assays. Clinical Infectious Diseases. 45(7). 826–836. 54 indexed citations
14.
Mazurek, Gerald H., Stephen E. Weis, Patrick K. Moonan, et al.. (2007). Prospective Comparison of the Tuberculin Skin Test and 2 Whole-Blood Interferon-  Release Assays in Persons with Suspected Tuberculosis. Clinical Infectious Diseases. 45(7). 837–845. 92 indexed citations
15.
LoBue, Philip & K Möser. (2005). Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003.. PubMed. 9(3). 333–8. 35 indexed citations
16.
LoBue, Philip & Kathleen Moser. (2004). Screening of Immigrants and Refugees for Pulmonary Tuberculosis in San Diego County, California. CHEST Journal. 126(6). 1777–1782. 36 indexed citations
17.
LoBue, Philip & Kathleen Moser. (2003). Use of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic. American Journal of Respiratory and Critical Care Medicine. 168(4). 443–447. 176 indexed citations
18.
Catanzaro, Antonino, Sharon Perry, Jill E. Clarridge, et al.. (2000). The Role of Clinical Suspicion in Evaluating a New Diagnostic Test for Active Tuberculosis. JAMA. 283(5). 639–639. 109 indexed citations
19.
LoBue, Philip & Antonino Catanzaro. (1999). Healthcare Worker Compliance With Nosocomial Tuberculosis Control Policies. Infection Control and Hospital Epidemiology. 20(9). 623–624. 5 indexed citations
20.
LoBue, Philip & Antonino Catanzaro. (1998). Effectiveness of a Nosocomial Tuberculosis Control Program at an Urban Teaching Hospital. CHEST Journal. 113(5). 1184–1189. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026